170 related articles for article (PubMed ID: 37738592)
1. Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
Erridge S; Sodergren MH
Inflamm Bowel Dis; 2024 Feb; 30(2):322-323. PubMed ID: 37738592
[No Abstract] [Full Text] [Related]
2. Reply: "Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?".
Glickman D; Dalessio S; Raup-Konsavage WM; Vrana KE; Coates MD
Inflamm Bowel Dis; 2023 Nov; 29(11):e42-e43. PubMed ID: 37738640
[No Abstract] [Full Text] [Related]
3. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
Ambrose T; Simmons A
J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
[TBL] [Abstract][Full Text] [Related]
4. Cannabis for inflammatory bowel disease.
Naftali T; Mechulam R; Lev LB; Konikoff FM
Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
Volz MS; Siegmund B; Häuser W
Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis.
Peppelenbosch MP; Parikh K; Fuhler G
J Crohns Colitis; 2019 Oct; 13(11):1479. PubMed ID: 30989193
[No Abstract] [Full Text] [Related]
8. An overview of cannabis based treatment in Crohn's disease.
Naftali T
Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):253-257. PubMed ID: 32149543
[No Abstract] [Full Text] [Related]
9. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases.
Kienzl M; Storr M; Schicho R
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00120. PubMed ID: 31899693
[TBL] [Abstract][Full Text] [Related]
10. Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases.
Quezada SM; Cross RK
Curr Gastroenterol Rep; 2019 Jan; 21(2):2. PubMed ID: 30635796
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
12. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis.
Goldenberg M; Reid MW; IsHak WW; Danovitch I
Drug Alcohol Depend; 2017 May; 174():80-90. PubMed ID: 28319753
[TBL] [Abstract][Full Text] [Related]
13. [Marihuana and cannobinoids as medicaments].
Tkaczyk M; Florek E; Piekoszewski W
Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098
[TBL] [Abstract][Full Text] [Related]
14. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature.
Nduma BN; Mofor KA; Tatang J; Ekhator C; Ambe S; Fonkem E
Cureus; 2023 Mar; 15(3):e36148. PubMed ID: 37065370
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Hasenoehrl C; Storr M; Schicho R
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
[TBL] [Abstract][Full Text] [Related]
16. The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation.
Graczyk M; Lewandowska AA; Dzierżanowski T
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361704
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies.
Vimal D; D'Souza LC; Rai V; Lal S; Sharma A; Gupta SC
Curr Med Chem; 2023; 30(2):178-202. PubMed ID: 35619266
[TBL] [Abstract][Full Text] [Related]
18. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M; De Toffol M; Kim JY; Choi MJ; Stubbs B; Thompson T; Firth J; Miola A; Croatto G; Baggio F; Michelon S; Ballan L; Gerdle B; Monaco F; Simonato P; Scocco P; Ricca V; Castellini G; Fornaro M; Murru A; Vieta E; Fusar-Poli P; Barbui C; Ioannidis JPA; Carvalho AF; Radua J; Correll CU; Cortese S; Murray RM; Castle D; Shin JI; Dragioti E
BMJ; 2023 Aug; 382():e072348. PubMed ID: 37648266
[TBL] [Abstract][Full Text] [Related]
19. Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.
Dalal RS; Palchaudhuri S; Snider CK; Lewis JD; Mehta SJ; Lichtenstein GR
Inflamm Bowel Dis; 2021 Mar; 27(4):500-506. PubMed ID: 32440693
[TBL] [Abstract][Full Text] [Related]
20. Cannabis finds its way into treatment of Crohn's disease.
Schicho R; Storr M
Pharmacology; 2014; 93(1-2):1-3. PubMed ID: 24356243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
